View in EDS HTML Full Text PDF Full Text

A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.

Saved in:
Bibliographic Details
Title: A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.
Authors: Tosefsky K; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; MD/PhD Program, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Lam JS; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Wang YN; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada., Keymanesh S; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Kuan AJ; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada., Metcalfe-Roach A; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada., Cirstea MS; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada., Sacheli MA; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada., Brett Finlay B; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada., Cohen TR; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada., Appel-Cresswell S; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
Source: Journal of Parkinson's disease [J Parkinsons Dis] 2026 Mar; Vol. 16 (2), pp. 332-350. Date of Electronic Publication: 2026 Feb 04.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: IOS Press Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-718X (Electronic) Linking ISSN: 18777171 NLM ISO Abbreviation: J Parkinsons Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41637153
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tosefsky+K%22">Tosefsky K</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; MD/PhD Program, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Lam+JS%22">Lam JS</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+YN%22">Wang YN</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Keymanesh+S%22">Keymanesh S</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Kuan+AJ%22">Kuan AJ</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Metcalfe-Roach+A%22">Metcalfe-Roach A</searchLink>; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Cirstea+MS%22">Cirstea MS</searchLink>; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Sacheli+MA%22">Sacheli MA</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Brett+Finlay+B%22">Brett Finlay B</searchLink>; Faculty of Science, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Cohen+TR%22">Cohen TR</searchLink>; Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Appel-Cresswell+S%22">Appel-Cresswell S</searchLink>; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; Faculty of Medicine, Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101567362%22">Journal of Parkinson's disease</searchLink> [J Parkinsons Dis] 2026 Mar; Vol. 16 (2), pp. 332-350. <i>Date of Electronic Publication: </i>2026 Feb 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22IOS+Press%22">IOS Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101567362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1877-718X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218777171%22">18777171 </searchLink><i>NLM ISO Abbreviation: </i>J Parkinsons Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41637153
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1877718X261418986
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 332
    Titles:
      – TitleFull: A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tosefsky K
      – PersonEntity:
          Name:
            NameFull: Lam JS
      – PersonEntity:
          Name:
            NameFull: Wang YN
      – PersonEntity:
          Name:
            NameFull: Keymanesh S
      – PersonEntity:
          Name:
            NameFull: Kuan AJ
      – PersonEntity:
          Name:
            NameFull: Metcalfe-Roach A
      – PersonEntity:
          Name:
            NameFull: Cirstea MS
      – PersonEntity:
          Name:
            NameFull: Sacheli MA
      – PersonEntity:
          Name:
            NameFull: Brett Finlay B
      – PersonEntity:
          Name:
            NameFull: Cohen TR
      – PersonEntity:
          Name:
            NameFull: Appel-Cresswell S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1877-718X
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of Parkinson's disease
              Type: main
ResultId 1